RNA vs EVMN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 09, 2026

RNA

49.8
AI Score
VS
RNA Wins

EVMN

45.4
AI Score

Investment Advisor Scores

RNA

50score
Recommendation
HOLD

EVMN

45score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric RNA EVMN Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -21.9% 0.0% EVMN
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 49.8/100 45.4/100 RNA
Profit Margin -184.1% 0.0% EVMN
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

RNA 1M: -14.9% · 3M: -16.7% EVMN 1M: -25.4% · 3M: -49.1%

Current Technical Phase

RNA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 31

RSI (14): 31.2 · Price: $10.36

EVMN

Markdown
Sell / avoid

Price below a falling SMA50 (slope -18.6%), weak momentum, RSI 33

RSI (14): 33.1 · Price: $10.54

Fundamentals Snapshot

Metric RNA EVMN
Market Cap
Forward P/E -1.3 -3.1
Trailing P/E
Revenue (TTM)
Revenue Growth -0.2% 0.0%
Gross Margin -0.6% 1.0%
Operating Margin -7.5% -10.2%
EPS -5.36 -11.52
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, RNA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.